Design and execute discovery experiments to evaluate the potential of our microglial cell therapy in Alzheimer’s disease.

Culture and differentiate iPSCs into CNS cell types, troubleshooting and optimizing 2D and 3D (organoids) protocols to support research experiments.

Develop and use 2D and 3D (organoids) in vitro disease models to investigate responses to Alzheimer’s disease-relevant challenges.

Design and optimize in vivo modeling approaches for Alzheimer’s disease, including selection of disease models, experimental groups, controls, time points, and readouts to evaluate microglial engraftment, function, and effects on disease-associated pathology.

Develop and optimize cellular and molecular assays to evaluate microglial function and disease-relevant phenotypes, including cytokine profiles and imaging-based readouts.

Design, troubleshoot, and perform experimental staining and fluorescence or confocal imaging for cultured cells, organoids, and brain tissue from Alzheimer’s disease in vivo models; interpret changes in microglial morphology, engraftment, and disease-associated pathology.

Partner with histology and imaging colleagues on routine sectioning, staining, and image acquisition, providing scientific guidance on experimental methods, image quality, and interpretation.

Integrate findings across in vitro experiments and in vivo tissue studies to refine hypotheses and determine next steps.

Analyze and present experimental results to internal teams and collaborators.

Collaborate effectively within the Microglia Therapeutics team and across Retro teams, including In Vivo, Computational Biology, and Automation.

Maintain an organized electronic lab notebook, contribute to supporting documents, and participate in lab organization and ordering.